Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors

Fig. 1

Kinetics of neutralizing antibodies in patients receiving immunotherapy and matched controls after vaccination with the first dose of the BNT162b2, mRNA-1273 and AZD1222 vaccine. On D22, patients had lower production of NAb inhibition titers compared to controls of similar age and gender (see text). Only 6 patients (10.7%) had NAb titers of equal or more than 50%

Back to article page